Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,369 | -13,458 | -7,950 | -16,902 | -13,414 |
| Depreciation Amortization | 4,736 | 2,925 | 1,367 | 5,570 | 4,054 |
| Accounts receivable | 6,177 | 9,178 | 5,781 | 1,238 | -1,076 |
| Accounts payable and accrued liabilities | 1,900 | 2,877 | 6,500 | -6,197 | -6,182 |
| Other Working Capital | 3,234 | 2,673 | 4,592 | -1,395 | -4,339 |
| Other Operating Activity | -5,322 | -9,725 | -11,289 | 6,903 | 8,938 |
| Operating Cash Flow | $-7,644 | $-5,530 | $-999 | $-10,783 | $-12,019 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,095 | 8,095 | 4,095 | -7,973 | -1,924 |
| PPE Investments | -241 | -262 | -160 | -1,088 | -748 |
| Purchase Sale Intangibles | -34 | -34 | -30 | -59 | -57 |
| Other Investing Activity | -34 | -34 | -30 | -57 | -55 |
| Investing Cash Flow | $7,820 | $7,799 | $3,905 | $-9,118 | $-2,727 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 87,190 | 52,886 | 22,500 | 14,000 | 0 |
| Debt Issued | 3,583 | 3,583 | N/A | N/A | N/A |
| Debt Repayment | -15,020 | -14,372 | -326 | -8,598 | -8,301 |
| Common Stock Issued | 2 | 2 | N/A | 11 | 11 |
| Other Financing Activity | -80,017 | -48,519 | -14,052 | -15,160 | -158 |
| Financing Cash Flow | $-4,262 | $-6,420 | $8,122 | $-9,747 | $-8,448 |
| Beginning Cash Position | 16,830 | 16,830 | 16,830 | 46,478 | 46,478 |
| End Cash Position | 12,744 | 12,679 | 27,858 | 16,830 | 23,284 |
| Net Cash Flow | $-4,086 | $-4,151 | $11,028 | $-29,648 | $-23,194 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,644 | -5,530 | -999 | -10,783 | -12,019 |
| Capital Expenditure | -241 | -262 | -160 | -1,088 | -748 |
| Free Cash Flow | -7,885 | -5,792 | -1,159 | -11,871 | -12,767 |